Abstract
The accompanying special issue reviews the role of eplerenone and spironolactone in the management of various cardiovascular and renal conditions.
Original language | English |
---|---|
Pages (from-to) | 1-2 |
Number of pages | 2 |
Journal | International Journal of Cardiology |
Volume | 200 |
DOIs | |
Publication status | Published - 23 Sept 2015 |
Keywords
- Cardiology
- Chronic kidney disease
- Heart failure
- HFpEF
- Hypertension
- Mineralocorticoid antagonists